HNB
MRNA icon

Huntington National Bank’s Moderna MRNA Stock Holding History

Huntington National Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
1,596
+100
+7% +$5.17K ﹤0.01% 1112
2026
Q1 		$76K Buy
1,496
+177
+13% +$8.26K ﹤0.01% 1181
2025
Q4 		$38.9K Sell
1,319
-1,319
-50% -$35.8K ﹤0.01% 1345
2025
Q3 		$68.1K Buy
2,638
+770
+41% +$21.5K ﹤0.01% 1141
2025
Q2 		$51.5K Sell
1,868
-196
-9% -$5.16K ﹤0.01% 1226
2025
Q1 		$58.5K Buy
2,064
+536
+35% +$19K ﹤0.01% 1119
2024
Q4 		$63.5K Buy
1,528
+324
+27% +$15.5K ﹤0.01% 1105
2024
Q3 		$80.5K Sell
1,204
-588
-33% -$54K ﹤0.01% 984
2024
Q2 		$213K Buy
1,792
+248
+16% +$31.4K ﹤0.01% 677
2024
Q1 		$165K Buy
1,544
+388
+34% +$39.1K ﹤0.01% 741
2023
Q4 		$115K Sell
1,156
-1,229
-52% -$103K ﹤0.01% 810
2023
Q3 		$246K Sell
2,385
-161
-6% -$18K ﹤0.01% 596
2023
Q2 		$309K Buy
2,546
+335
+15% +$44.7K ﹤0.01% 572
2023
Q1 		$340K Buy
2,211
+684
+45% +$113K ﹤0.01% 527
2022
Q4 		$274K Buy
1,527
+515
+51% +$84.2K ﹤0.01% 569
2022
Q3 		$120K Buy
1,012
+139
+16% +$21.1K ﹤0.01% 717
2022
Q2 		$124K Sell
873
-219
-20% -$31.3K ﹤0.01% 736
2022
Q1 		$188K Buy
1,092
+620
+131% +$104K ﹤0.01% 664
2021
Q4 		$119K Buy
472
+153
+48% +$44.7K ﹤0.01% 805
2021
Q3 		$122K Buy
319
+79
+33% +$29.1K ﹤0.01% 708
2021
Q2 		$56K Hold
240
– – ﹤0.01% 914
2021
Q1 		$31K Sell
240
-110
-31% -$15.9K ﹤0.01% 995
2020
Q4 		$36K Hold
350
– – ﹤0.01% 920
2020
Q3 		$25K Buy
350
+250
+250% +$17.4K ﹤0.01% 974
2020
Q2 		$6K Buy
+100
New +$5.48K ﹤0.01% 1296

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Huntington National Bank's MRNA Position: Q2 2026 in Review

Huntington National Bank increased its Moderna (MRNA) stake by 6.7% in Q2 2026, buying an estimated $5.17K and bringing the position to 1,596 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

Huntington National Bank first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $340K in Q1 2023. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Huntington National Bank held 1,596 shares of Moderna worth $112K as of Q2 2026.
  • Huntington National Bank bought 100 Moderna shares in Q2 2026, an estimated $5.17K.
  • Moderna made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1112 holding.
  • Huntington National Bank first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • Huntington National Bank's Moderna position peaked at $340K in Q1 2023.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.